Institutional Ownership
Biocryst Pharmaceuticals Inc
CUSIP 09058V103COMBCRXQ1 2026
13D / 13G Filings
46
Schedule 13D/13G on record
Beneficial Filers
18
Distinct reporting persons
Largest Stake
10.2%
Max % of class reported
Institutional Holders
290
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
46 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Deerfield Mgmt, L.P. | 13G/A | 6.8% | 14.34M | SEC |
| 2 | Feb 9, 2026 | State Street Corporation | 13G | 5.3% | 11.07M | SEC |
| 3 | Nov 12, 2025 | Ra Capital Management, L.P. | 13G | 7.3% | 15.30M | SEC |
| 4 | Sep 19, 2025 | Deerfield Mgmt, L.P. | 13G | 5.8% | 12.17M | SEC |
| 5 | May 15, 2025 | Avoro Capital Advisors LLC | 13G/A | 4.2% | 8.70M | SEC |
| 6 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 8.4% | 17.48M | SEC |
| 7 | Nov 7, 2024 | Vanguard Group Inc | 13G/A | 10.0% | 20.73M | SEC |
| 8 | Nov 7, 2024 | Vanguard Group Inc | 13G/A | 9.8% | 20.31M | SEC |
| 9 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 9.8% | 20.31M | SEC |
| 10 | Oct 17, 2024 | State Street Corp | 13G/A | 4.3% | 8.85M | SEC |
36 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Biocryst Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 22.65M | $215.64M |
| 2 | Ra Capital Management, L.P. | 15.83M | $150.67M |
| 3 | Deerfield Management Company, L.P. | 15.04M | $143.16M |
| 4 | State Street Corp | 12.21M | $116.22M |
| 5 | Tcg Crossover Management, LLC | 11.02M | $104.92M |
| 6 | Janus Henderson Group PLC | 8.91M | $84.85M |
| 7 | Perceptive Advisors LLC | 7.43M | $70.77M |
| 8 | Vestal Point Capital, LP | 7.03M | $66.88M |
| 9 | Two Sigma Investments, LP | 6.39M | $60.86M |
| 10 | Geode Capital Management, LLC | 5.78M | $55.06M |